Treatment of Mycosis Fungoides With Hypericin Ointment and Visible Light
Status:
Not yet recruiting
Trial end date:
2025-05-31
Target enrollment:
Participant gender:
Summary
The goal of this clinical trial is to assess the benefit of continuous treatment with
synthetic hypericin ointment (HyBryte) and visible light in patients with mycosis fungoides
for up to 12 months (54 weeks).